PATIENTS with leukemia, metastatic carcinoma and sarcoma possess altered carbohydrate metabolism as shown by reduced glucose tolerance (Marks and Bishop, 1957) , and elevated resting venous lactic acid (Cori and Cori, 1925). Enzymes concerned in tissue glycolysis are often increased in activity in serum during neoplastic disease progression, including phosphohexose isomerase (Bodansky, 1954b), aldolase (Sibley Fleischer and Higgins, 1955) , and lactic dehydrogenase (Hill and Levi, 1954). Acid phosphomonoesterases hydrolyzing three-carbon substrates produced during glycolysis are also increased in activity in venous blood from patients with breast and prostate cancer (Reynolds, Lemon and Byrnes, 1956 
the patier-ts studied.
In the statistical evaluation of data, only the initial serum-observation was utilized for the comparison of means between different groups of patients with various diseases. This tends to underestimate the frequency of elevated blood citric acid, which is more frequent in the more advanced stages of cancer, but is iiecessary for a true comparison between cancer and other diseases, in which only a single observation was available for each case. Hypercitricemia has been defined as serum citrate value exceeding twice the standard deviation of the mean of healthy volunteers of the same sex, a value which is at the 95 per cent level of confidence for abnormality. RESULTS 
Citrate dynamics
The increase of serum citrate from 0-5 minutes A) was regarded as the result of rapid dilution of the 0-5 g. dose into plasma and extracellular fluid, an * The analytic procedure has repeatedly yielded 95-98 per cent recovery of citrate added to whole blood or serum. Excellent checks within 2-3 per cent accuracy have been obtained when duplicate analyses for citrate were carried out using the method reported by Saffron and Dendstadt (1948) . All sera were immediatley frozen upon separation from clot and analyses should be carried out within a few days of collection. Frozen sera may show [5] [6] [7] [8] [9] [10] Total 358 assumptioii which appears valid (Bunker, Stetson, Coe, Grillo, and Murphy, 1955) . This distribution space S was determined by dividing the total in Itg. (0-5 x 106) by A given in jig. per ml. In healthy volunteers and cancer patients the mean for this space was 21-6 liters for males and 14-0 liters for females (Table 11) .
Following the peak concentration of citrate 5 minutes after start of injection serum citrate concentration rapidly declined in a semilogarithmic manner compatible with a first order reaction, the initial baseline concentration very nearly being attained in normal, arthritic and cancer patients at 30 minutes time (Lemon, Mueller, Looney, Chasen and Kelman, 1959) . The rate of decrease of serum citrate concentration approximated I jig. /ml. /min., which when multiplied by 8 x 60 in each case provided an estimate of the hourly rate of citrate clearance from plasma and extracellular fluid, by diffusion, metabolism, and renal excretion. In normal males, plasma clearance approximated 900 mg. per hour and in females, 800 mg. per hour. Urinary citrate excretion was not measured, since preliminary studies showed poor correlation between serum and urine citrate concentration.
Citrate excretion in the urine appears to fluctuate quite independently of serum values owing to high renal uptake and metabolism (Herndon and Freeman, 1958) . Only a small fraction of plasma citrate passing through the kidney is excreted, the amount being affected by acid-base balance and vitamin D content of the diet (Yarbo, 1956 ).
Fa-sting venoU8citrate concentration-s and di8ea8e
In conformity with observations published by Rechenberger and Benndorf while this study was underway (Rechenberger and Benndorf, 1956) , the mean venous citrate concentration of healthy females was found to exceed that of males of comparable age groups ( Fig. 1 In one patient with breast cancer, citrate clearance was simultaneously measured in mixed venous blood, and in venous blood passing through the primary tumour. The citrate clearance rate was identical in both areas, according to our method of calculation (Table IV) . This suggests that the difference in blood citrate concentration in the two sites was not due to uptake of citrate by the neoplasm.
These results would suggest increased citrate diffusion from some body tissue accounting for the increased blood level, rather than reduced tissue utilization in carcinomatosis. Bone which contains over 1 per cent citrate (dry weight), in its organic matrix (Dickens, 1941 ; Thunberg, 1953 ) is one of the more obvious sources for citrate release, but metastatic cancer and malignant tumour cells themselves contain considerable amounts of citrate (Potter and Busch, 1950; Dietrich and Shapiro, 1956; Miller and Carruthers, 1950 
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A sex difference was not seen however in either of two groups of non-breast cancer patients, in whom the average male distribution space approached the female value. Male rheumatoid arthritic patients, on the other hand possessed a higher mean distribution space for citrate than healthy volunteers, and were significantly different in this respect from all groups of male or female patients with active metastatic cancer of breast as well as other types of cancer (p < -012). These results suggest that the tissues of patients with rheumatoid arthritis are more widely and rapidly permeable to injected citrate resulting in a 5 minute postinjection peak value which is considerably smaller than observed in patients with cancer, or healthy volunteers, as a result of dilution. This observation may be related to the unusual property of citric acid in solubilizing pro-collagen (Jackson, 1957 (Lemon, 1959 It was striking to note the recurrently elevated blood citrate values when patients relapsed while on adrenal corticoid therapy (Table XI) . (Kissin and Kreeger, 1954; Chang and Freeman, 1950b) . In this latter case, a negative calcium balance and hypercalcemia might be expected to accompany hypercitricemia, as we have observed in one case of functioning parathyroid carcinoma and in occasional mammary cancer patients. Intensive osseous destruction, although present roentgenologically in many of the hypercitricemia breast cancer patients, was not severe enough to induce hypercalcemia in most of these patients and may be coincidental, rather than contributory. Gomori and Gulyas (1944) were the first to observe that parenteral administration of sodium citrate in dogs leads to marked hypercalcuria with i 'mal alteration in serum calcium concentration. Their work has been confirmed (Chang and Freeman, 1950a) , indicating that in the absence of hyperparathyroidism and its attendant metabohc disturbance hypercitricemia may produce a ten to twenty fold augmentation of calcium excretion without raising total serum calcium concentration above 12 mg. per cent. This may be the result of a marked increase in the ultra-filterable fraction of plasma calcium which is citrate bound, or because of diminished tubular reabsorption of the calcium citrate complex. These observations bowever help to explain the rare coexistance of hypercitricemia and hypercalcemia in our cancer population.
Hormoiial factors such as insulin (Pincus, Natelson and Lu-uovov. 1.949), epinephrine (Pincus, Na-telson and Lugovoy, 1951) Lemon and Byrnes, 1956) . We have also found that marrow siiiiisoid blood is far higher in acid phosphatase activity, than peripheral arterial or venous blood (Reynolds, Lemon, Kaplan, Idelson, Mueller and Derow, 1959) . Likewise, abnormal venous phosphohexose isomerase activity is often preseiit in iiiami-iiary carcinoma with osseous invasion (Bodansky, 1954a) , aiid elevated alkaline phosphatase activity is well knowi-i to result from osseoiis or hepatic invasion by tumour.
Since the early reports of Dickens and others coi-iceriiiiig the presei-ice of citrate in the organic matrix of vertebrate bone (Dickens, 1941 ; Thunberg, 1953) (Plimpton and Gellhorn, 1956) . A calciunibiiiding substance has been postulated in those cases in whom an elevated seran-i alkaline phosphatase suggested bone disease.
Normal prostatic and mammary epithelium secrete extremely high conceiitratioiis of citric acid into their respective secretions as a result of specific sex hormonal stimulation (Mann, 1954 ; Lenner, 1934) (Neumann and Neumann, 1958) . Neoplastic invasion of soft tissues may also be facilitated by citrate induced solvation of procollagen (Jackson, 1957) .
Numerous observations attest to the striking ability of cortisone and prednisone therapy to control hyperealcemia in cancer, and to induce recalcification of osseous metastases in breast cancer, coincidental with reduction of circulating citrate concentration to normal (Lemon, 1956 (Lemon, , 1957 (Lemon, , 1959 Nissen-Meyer, 1957 (Pearson, Li, MacLean, Lipsett, and West, 1955 ; Rusch, 1956 (Hastings, MacLean, Eichelberger, Hall and Da Costa, 1934 In most of the adult surgical patients in whom massive replacement of blood is necessary, extreme activation of the pituitary-adrenocortical system by the underlying catastrophic disease probably contributed to hypercitricemia, by impairing the metabolism of exogenous citrate, such as we have observed occurs after adrenal cortical steroid therapy.
Cookson and co-workers have suggested that hypothermia which has been utilized in vascular surgery may compound the hazard by further reduction of ability to utilize large amounts of administered citrate (Cookson, Costas-Durieux and Bailey, 1954) . Anoxia per se may also induce hypercitricemia (Hallman and Forsander, 1952 ).
Bunker and co-workers obtained fairly satisfactory agreement between the observed increment in arterial citrate concentration after infusion (average in 11 patients=13-7 mg./100 c.c.) and the increment predicted on the basis of equilibration in extracellular fluid within 6-16 minutes (average=11.2 mg./100 c.c.) If the latter figure is corrected for the mean rate of fall we -have noted in serum citrate concentration after termination of infusion, approximately 1 #g.1 ml./minute in both sexes in the period 5-30 minutes after injection, the expected citrate concentration would be 12-5 mg./100 c.c. from their data, on the assumption that the clearance process begins immediately with initial elevation of serum citrate. It is likely that the amount of protein bound calcium was overestimated from the total protein concentrations observed in many of the patients with hepatic cirrhosis in the series reported by Bunker et al. (1955) in whom a considerable increase in gamma globulin fraction could be expected, which has been found to have only slight calcium binding capacity (Carr, 1955 (Howland, Bellville, Zucker, Boyan and Cliffton, 1957) .
SUMMARY
Citric acid concentration has been measured using the pentobromoacetone procedure in blood from bone marrow, arterial and venous sites, in 358 healthy volunteers, arthritics and patients with various types of cancer in all stages. The clearance of exogenous citrate from blood has been estimated in a representative fraction of each group of patients and approximates 0 9 g. per hour. Women have been found to have consistently higher fasting venous serum citric acid than men, with a slightly lower citrate clearance rate. Bone marrow blood consistently shows the highest concentration of citrate, followed by arterial and finally venous blood. Venous citric acid concentrations greater than twice the S.D. from the mean for each sex (" hypercitricemia ") occurred in 4-2 per cent of healthy volunteers, in 4-6 per cent of all patients with benign diseases, in 11 1 per cent of patients with pre-malignant tumors, and in 23-6 per cent of patients with lancer. Anorexia and weakness were generally noted in the latter group. Hypercalcemia exceeding 12 mg. per cent (6 m-equiv./l.) was noted in only 3 patients in the entire series, but abnormal acid phosphatase and lactic dehydrogenase activity usually accompanied hypercitricemia. Advanced carcinomas of the breast, prostate, and lung were most commonly associated with hypercitricemia, probably as a result of osseous metastases. Prednisone therapy in advanced mammary carcinoma usually reduced elevated blood citric acid to normal simultaneously reducing by 28 per cent the utilization of administered citrate, indicating the probable suppression of tumor growth in osseous and perhaps in other metastatic sites.
